Patients at the Parrish Healthcare Center in Titusville, Fla., are the first to have access to enhanced comfort during Magnetic Resonance (MR) exams thanks to the installation of the nation’s first Vantage Titan / Zen Edition 1.5T MR Theater from Canon Medical Systems USA Inc. The new MR theater projects peaceful, virtual reality

GE Healthcare and Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., have started a second Phase 3 clinical trial of Flurpiridaz 18F (called the AURORA study), an investigational agent being evaluated for the detection of coronary artery disease (CAD), the most common form of heart disease.1 CAD affects an estimated

Patient presents with bilateral bulging varicosities   By Ajit Naidu, MD An estimated one-third of the population in Western countries has untreated venous disease.[i] Some of these individuals have lived with debilitating symptoms of venous insufficiency for a decade or more because their primary care physicians or OB/GYNs have told

  Stradis Healthcare, a provider of custom procedure trays and minor kits, has had several big events this summer, including earning ISO 13485:2016 certification for its Waukegan, Ill., facility; hiring two new executives; and overhauling its website, stradishealthcare.com. .               Stradis serves more than 1,500 surgical centers, private practices and purchasing

ViewRay Inc., the Oakwood Village-based maker of an MRI-guided radiation therapy system called MRIdian, has named medical device industry veterans Scott Drake as president and CEO, and Shar Matin as COO, effective immediately. Both men had been executives at Spectranetics Corp., a developer and manufacturer of minimally invasive cardiovascular devices,

EchoNous, a Seattle provider focused on delivering intelligent medical tools, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the EchoNous Vein, an ultrasound-based tool designed specifically for nurses to improve peripheral IV (PIV) catheter placements. Developed for usage across a wide range of patients including both adults

 By David Muhlestein, PhD, JD and Lia Winfield, PhD Dramatic changes in the demographics of our physician population are happening at the same time as our healthcare system is making equally dramatic changes in how it organizes and pays for care. This new generation of physicians is likely to be

QT Vascular has agreed to sell its non-drug coated coronary products to Teleflex, including its Chocolate XD and Glider, with an option to purchase its Chocolate Heart drug-coated coronary balloon catheter which is currently under development. Singapore-based QT Vascular has not released any financial details of the agreement, but said that it

Canton, Ohio-based medical device startup Sonavex. A John Hopkin spinout, received clearance from the U.S. Food and Drug Administration to market implantable devices to be used with ultrasound imaging, CEO David Narrow said. The 510(k) clearance means the Johns Hopkins spinout startup has regulatory approval for its initial product. The Echomark devices are designed to

Obesity results from excess white fat storage, making it difficult to treat because the effectiveness of diet, exercise, and systemic anti-obesity agents is limited, and in the latter case may cause serious side effects. As a result, researchers are investigating innovative strategies for localized delivery of fat burning compounds via